End Kidney Deaths Act

Bill 118 HR 9275, also known as the End Kidney Deaths Act, is a piece of legislation introduced in the US Congress with the goal of addressing the high rate of kidney-related deaths in the country. The bill aims to improve access to kidney care, increase funding for research on kidney diseases, and promote early detection and treatment of kidney issues.

One of the key provisions of the End Kidney Deaths Act is the establishment of a national kidney disease registry, which would collect data on patients with kidney diseases and track outcomes to better understand the prevalence and impact of these conditions. This registry would help researchers and healthcare providers identify trends and develop more effective treatments for kidney diseases.

Additionally, the bill includes measures to increase funding for kidney disease research, including grants for innovative research projects and clinical trials. This funding would support efforts to develop new treatments and technologies for kidney diseases, as well as improve access to care for patients with kidney issues. The End Kidney Deaths Act also aims to promote early detection and treatment of kidney diseases by expanding access to screening and diagnostic services. This includes increasing funding for community health centers and other healthcare providers to offer kidney screenings to at-risk populations, as well as implementing educational programs to raise awareness about the importance of kidney health. Overall, the End Kidney Deaths Act is a comprehensive piece of legislation that seeks to address the high rate of kidney-related deaths in the US through improved access to care, increased research funding, and early detection and treatment initiatives. If passed, this bill has the potential to make a significant impact on the lives of individuals with kidney diseases and reduce the overall burden of kidney-related deaths in the country.